• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AADE to Work on Diabetes Prevention With Truck Drivers, Other At-Risk Groups


Truck drivers were identified in a Gallup survey as the profession most at risk for type 2 diabetes.

CDC has selected the American Association of Diabetes Education (AADE) to work with truck drivers and ethnic groups that have limited access to the National Diabetes Prevention Program (DPP). AADE will create new sites to offer the evidence-based lifestyle change program, working with partners that include the advocacy group UnidosUS and the digital behavioral health provider Omada Health, as well as the Healthy Trucking Association of America.

Truck drivers were identified as the profession most at-risk for type 2 diabetes (T2D) in a Gallup-Sharecare survey released this summer. AADE will also target Hispanic, Native American, and African American communities, who have higher rates of T2D than whites.

The DPP is a yearlong program with a CDC-approved curriculum; it features 16 weekly core sessions, followed by a maintenance period of monthly sessions. Evidence shows the program stops prediabetes from progressing as participants make modest changes and lose 5% to 7% of body weight. In clinical trials, people with prediabetes who took part in the DPP compared with a group taking metformin were 58% less likely to progress to T2D.

This is the second time CDC has looked to AADE to scale the National DPP. Over the past 5 years, the organization has used its diabetes self-management education and support (DSMES) network to scale the DPP. A presentation at AADE’s summer meeting in 2016 outlined why the network is poised to bring diabetes prevention to all 50 states when Medicare starts reimbursement in 2018. One reason: many diabetes educators are already offering prevention services, but simply haven’t been reimbursed for them.

AADE will try to bridge gaps in areas of the South and Southwest with high rates of diabetes that lack National DPP programs. Targeted states include Alabama, Arkansas, Arizona, Georgia, Louisiana, Mississippi, New Mexico, and Texas, as well as parts of California with underserved Hispanic communities.

A proposed rule calls for Medicare to start paying for the DPP in April 2018, but CMS does not plan to include virtual providers the first year. Virtual providers have protested that CMS has plenty of evidence that these programs work just as well in reducing the risk of progression to T2D as traditional in-person programs. In its proposed rule CMS called for more testing before reimbursement would occur.

Spokesmen for both AADE and Omada Health said this was a separate project and not designed to generate data for that purpose.

“We identified a priority population, men, and designed a project that would meet their needs. Over the road truck drivers do not have consistent access to face-to-face programs,” said Matthew Eaton of AADE. “By working with Omada, we will be able to provide this population with access to a quality National Diabetes Prevention Program."

Bringing services to people with diabetes or at risk of developing the disease can be a challenge in remote areas. CDC published a study earlier this year that found a disconnect between poor, minority populations in need of DSMES and the programs themselves. A major hurdle is the limited way CMS pays for diabetes education.

Virtual providers have noted a similar pattern exists in prevention programs that have CDC recognition; they argue that a combination of virtual and in-person programs is needed to reach underserved communities as well as people in jobs who can’t show up at the same place every week.

“Innovations in technology are creating opportunities that increase access for the people with and at risk for diabetes,” AADE President Nancy D’Hondt, RPh, CDE, FAADE, said in a statement. “Virtual options are both timely and convenient for those who need it the most.”

Related Videos
Chase D. Hendrickson, MD, MPH
Dr Jeffrey Sippel
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Lalan Wilfongd, MD, US Oncology Network
Ben Urick, PharmD, PhD
Bincy Abraham, MD
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Related Content
© 2023 MJH Life Sciences
All rights reserved.